{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:35Z","timestamp":1792270955194,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03249-9","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:14:49Z","timestamp":1771564489000},"page":"1284-1297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of perioperative thrombopoietin receptor agonists in patients with immune thrombocytopenia and thrombocytopenia secondary to chronic liver disease undergoing elective\u00a0procedures: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"59","author":[{"given":"Ishwa","family":"Shakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehmat","family":"Fayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab Muhammad","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Safwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nabeel","family":"Saddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Awais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Shamoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbsaat","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"1","key":"3249_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/09537104.2020.1859102","volume":"33","author":"I Lindquist","year":"2022","unstructured":"Lindquist I, Olson SR, Li A, Al-Samkari H, Jou JH, McCarty OJT, Shatzel JJ (2022) The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis. Platelets 33(1):66\u201372. https:\/\/doi.org\/10.1080\/09537104.2020.1859102","journal-title":"Platelets"},{"issue":"1","key":"3249_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12072-022-10421-9","volume":"17","author":"Z Ding","year":"2023","unstructured":"Ding Z, Wu H, Zeng Y, Kuang M, Yang W, Meng Z, Chen Y, Hao C, Zou S, Sun H, Liu C, Lin K, Shi G, Wang X, Fu X, Chen R, Chen Y, Liang R, Kano T, Pan H, Yang Suna, Fan Jia, Zhou J (2023) Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures. Hepatol Int 17(1):180\u2013189. https:\/\/doi.org\/10.1007\/s12072-022-10421-9","journal-title":"Hepatol Int"},{"issue":"2","key":"3249_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","volume":"54","author":"R Tateishi","year":"2019","unstructured":"Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M (2019) A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation. J Gastroenterol 54(2):171\u2013181. https:\/\/doi.org\/10.1007\/s00535-018-1499-2","journal-title":"J Gastroenterol"},{"issue":"3","key":"3249_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","volume":"155","author":"N Terrault","year":"2018","unstructured":"Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T (2018) Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology 155(3):705\u2013718. https:\/\/doi.org\/10.1053\/j.gastro.2018.05.025","journal-title":"Gastroenterology"},{"issue":"4","key":"3249_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.30561","volume":"70","author":"M Peck-Radosavljevic","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A, Makara M, Ben Ari Z, Braun M, Mitrut P, Yang SS, Akdogan M, Pirisi M, Duggal A, Ochiai T, Motomiya T, Kano T, Nagata T, Afdhal N (2019) Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2). Hepatology (Baltimore, Md.) 70(4):1336\u20131348. https:\/\/doi.org\/10.1002\/hep.30561","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"3249_CR6","doi-asserted-by":"publisher","first-page":"497.e1","DOI":"10.1016\/j.jtct.2021.02.033","volume":"27","author":"GE Christakopoulos","year":"2021","unstructured":"Christakopoulos GE, DeFor TE, Hage S, Wagner JE, Linden MA, Brunstein C, Bejanyan N, Verneris MR, Smith AR (2021) Phase I dose-finding, safety, and tolerability trial of romiplostim to improve platelet recovery after UCB transplantation. Transpl Cell Ther 27(6):497.e1-497.e6. https:\/\/doi.org\/10.1016\/j.jtct.2021.02.033","journal-title":"Transpl Cell Ther"},{"issue":"4","key":"3249_CR7","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65\u2013W94. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00136","journal-title":"Ann Intern Med"},{"key":"3249_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"3249_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Method Med Res 27(6):1785\u20131805. https:\/\/doi.org\/10.1177\/0962280216669183","journal-title":"Stat Method Med Res"},{"key":"3249_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clin Res ed.) 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ (Clin Res ed.)"},{"issue":"7414","key":"3249_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"9","key":"3249_CR12","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1016\/S2352-3026(20)30227-1","volume":"7","author":"DM Arnold","year":"2020","unstructured":"Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG (2020) Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol 7(9):e640\u2013e648. https:\/\/doi.org\/10.1016\/S2352-3026(20)30227-1","journal-title":"Lancet Haematol"},{"issue":"8","key":"3249_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1110709","volume":"367","author":"NH Afdhal","year":"2012","unstructured":"Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group (2012) Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med 367(8):716\u2013724. https:\/\/doi.org\/10.1056\/NEJMoa1110709","journal-title":"N Engl J Med"},{"issue":"6","key":"3249_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/09537104.2018.1542125","volume":"30","author":"SR Olson","year":"2019","unstructured":"Olson SR, Koprowski S, Hum J, McCarty OJT, DeLoughery TG, Shatzel JJ (2019) Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution? Platelets 30(6):796\u2013798. https:\/\/doi.org\/10.1080\/09537104.2018.1542125","journal-title":"Platelets"},{"issue":"6","key":"3249_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","volume":"17","author":"H Hidaka","year":"2019","unstructured":"Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M (2019) Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures. Clin Gastroenterol Hepatol 17(6):1192\u20131200. https:\/\/doi.org\/10.1016\/j.cgh.2018.11.047","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3249_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bja.2018.09.010","volume":"122","author":"A Nagrebetsky","year":"2019","unstructured":"Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP (2019) Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth 122(1):19\u201331. https:\/\/doi.org\/10.1016\/j.bja.2018.09.010","journal-title":"Br J Anaesth"},{"issue":"6","key":"3249_CR17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jhep.2014.07.007","volume":"61","author":"NA Terrault","year":"2014","unstructured":"Terrault NA, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM (2014) Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol 61(6):1253\u20131259. https:\/\/doi.org\/10.1016\/j.jhep.2014.07.007","journal-title":"J Hepatol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03249-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:04:00Z","timestamp":1783098240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03249-9","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Availability of data is not applicable as this study involves publicly available data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Consent for publication is not applicable as this study involves publicly available data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No AI tools or technologies were used in the preparation of any part of this\u00a0manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of generative AI and AI-assisted technologies"}}]}}